Literature DB >> 15247882

Mechanisms of type I interferon signaling in normal and malignant cells.

Yongzhong Li1, Kishore K Srivastava, Leonidas C Platanias.   

Abstract

Type I interferons (IFNs) are cytokines that induce multiple biological effects on target cells, including antiviral, antiproliferative, and immunomodulatory activities. Consistent with the pleiotropic nature of these cytokines, multiple signaling pathways are activated during binding of IFNs to the type I IFN receptor. An important signaling cascade activated by type I IFNs is the Jak-Stat pathway. Activation of the Tyk-2 and Jak-1 kinases, and downstream formation of various Stat complexes, mediates IFN-dependent gene transcription for IFN-stimulated genes. In addition to the classic Jak-Stat pathway, type I IFNs activate multiple other pathways, including the insulin receptor substrate-phosphatidylinositol 3'-kinase cascade, the CBL-CrkL pathway, and mitogen-activated protein kinase pathways. There is accumulating evidence that non-Stat IFN-regulated signaling pathways play important roles in the generation of the antiproliferative effects of type I IFNs. In this review, the regulation of various signaling cascades by the type I IFN receptor is summarized and an update on recent advances in the field is provided.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15247882

Source DB:  PubMed          Journal:  Arch Immunol Ther Exp (Warsz)        ISSN: 0004-069X            Impact factor:   4.291


  6 in total

Review 1.  IFNs-signaling effects on lung cancer: an up-to-date pathways-specific review.

Authors:  Vasiliki Galani; Michalis Kastamoulas; Anna Varouktsi; Evangeli Lampri; Antigoni Mitselou; Dimitrios L Arvanitis
Journal:  Clin Exp Med       Date:  2016-07-14       Impact factor: 3.984

2.  Adaptive antiviral immunity is a determinant of the therapeutic success of oncolytic virotherapy.

Authors:  Paul T Sobol; Jeanette E Boudreau; Kyle Stephenson; Yonghong Wan; Brian D Lichty; Karen L Mossman
Journal:  Mol Ther       Date:  2010-11-30       Impact factor: 11.454

3.  Differentially regulated interferon response determines the outcome of Newcastle disease virus infection in normal and tumor cell lines.

Authors:  Sateesh Krishnamurthy; Toru Takimoto; Ruth Ann Scroggs; Allen Portner
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

4.  Regulation of RANTES promoter activation in gastric epithelial cells infected with Helicobacter pylori.

Authors:  Takahiko Kudo; Hong Lu; Jeng Yih Wu; David Y Graham; Antonella Casola; Yoshio Yamaoka
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.441

5.  Anti-tumorigenic effects of Type 1 interferon are subdued by integrated stress responses.

Authors:  S Bhattacharya; W-C HuangFu; G Dong; J Qian; D P Baker; J Karar; C Koumenis; J A Diehl; S Y Fuchs
Journal:  Oncogene       Date:  2012-10-08       Impact factor: 9.867

6.  Differential regulation of protein kinase C isoforms of macrophages by pathogenic and non-pathogenic mycobacteria.

Authors:  Shivendra K Chaurasiya; Kishore K Srivastava
Journal:  Mol Cell Biochem       Date:  2008-07-24       Impact factor: 3.396

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.